Sight Sciences Announces Appointment of Brenda Becker to Board of Directors
Legislative and health policy expert brings extensive private and public sector experienceMENLO PARK, Calif., March 16, 2022 (GLOBE NEWSWIRE) --...
News
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain
VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF...
Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment
CAMBRIDGE, Mass., March 16, 2022 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical...
Cytovia Therapeutics to Present Preclinical Data for iPSC-derived NK Cells and Flex-NK™ Engager Multispecific Antibodies at 2022 AACR Annual Meeting
AVENTURA, Fla. and NATICK, Mass., March 16, 2022 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK)...
A Leading Healthcare Provider Selected Healthcare Triangle’s (HCTI) AWS Cloud Services offerings to Improve Uptime of EHRs
Healthcare Triangle, Inc. (HCTI), one of the largest AWS premier partners, helped a comprehensive healthcare provider in Southeast Iowa to improve uptime...
Dialco Medical Announces Formation of Medical Advisory Board to Support the Continued Development of DIMI Device
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its...
Palisade Bio (Nasdaq: PALI) Announces Analysis Demonstrating LB1148 Reduced the Extent and Severity of Post-Surgical Intraabdominal Adhesions by 93%
Data from Pooled-Analysis of Enteral Protease Inhibitor LB1148 Demonstrated 72% Reduction in the Risk of Adhesion Formation in Patients Undergoing...
Sema4 Announces Nationwide Expansion of Disparity Study to Deliver Precision Oncology Care to Underserved Communities
- The REPRESENT Study Will Create One of the Most Diverse and Comprehensive Clinico-genomic Datasets to Uncover and Address Disparities...
SOTIO Announces Oral and Multiple Poster Presentations on Key Clinical Programs at the American Association of Cancer Research Annual Meeting (AACR) 2022
Oral presentation will focus on interim efficacy and safety data from the Phase 1/1b AURELIO-03 study of SOT101 in combination...
Baudax Bio Reports 2021 Fourth Quarter and Annual Financial Results
Units Sold by Quarter Units Sold by Quarter Quarterly Customer Sales / Quarterly ASC Sales Quarterly Customer Sales / Quarterly...
Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics
NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...
Prelude Therapeutics Reports Full Year 2021 Financial Results
Significant progress achieved in 2021: Pipeline now includes six internally discovered small molecule compounds targeting clinically validated pathways in cancers...
VitalHub Announces Expansion Licensing Deal With Liverpool Heart and Chest Hospital NHS Foundation Trust
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce an...
Ocuphire Completes Enrollment of Over 100 Subjects in 24-Week ZETA-1 Phase 2b Trial of Oral APX3330 for the Treatment of Diabetic Retinopathy
Successful Execution and Completion of Enrollment in Four Late-Stage Clinical Trials Across Nyxol and APX3330 Programs in First Quarter of...
KemPharm Earns $1.975 Million Fee from Corium Following FDA Approval of the Corium Product ADLARITY® (donepezil transdermal system)
KemPharm team provided development and regulatory services to Corium pursuant to a master development services agreement CELEBRATION, Fla., March 16,...
Long-Term Phase 3 Data Show ADUHELM® Continues to Reduce Underlying Pathologies of Alzheimer’s Disease in Patients Treated for More Than Two Years
ADUHELM continued to reduce two key Alzheimer’s disease pathologies, amyloid beta plaques and p-tau181, in patients treated for up to...
Healthcare of Ontario Pension Plan (HOOPP) posts 11.28% return in 2021, funded status is 120%
HOOPP President & CEO Jeff Wendling HOOPP President & CEO Jeff WendlingTORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- The Healthcare...
AIM ImmunoTech Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Ampligen® for the Treatment of Locally Advanced Pancreatic Cancer
Prof. Casper H.J. van Eijck, MD, PhD Prof. Casper H.J. van Eijck, MD, PhDData seen to date indicates that Ampligen®...
Plantable Health’s Innovative Dietary Intervention Program Qualifies for Health Savings Account Reimbursement
New York, New York--(Newsfile Corp. - March 16, 2022) - Plantable® Health Inc. (NEO: PLBL) ("Plantable" or the "Company") today...
Rritual Superfoods Announces DTC Eligibility of Its Common Shares in the United States
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2022) - Rritual Superfoods Inc. (CSE: RSF) (FSE: 0RW) (OTCQB: RRSFF) ("Rritual" or the "Company") is...
